Ubs Asset Management Americas Inc Alnylam Pharmaceuticals, Inc. Transaction History

Ubs Asset Management Americas Inc

  • $477 Billion
  • Q2 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 958,336 shares of ALNY stock, worth $433 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
958,336
Previous 736,111 30.19%
Holding current value
$433 Million
Previous $199 Million 57.22%
% of portfolio
0.07%
Previous 0.05%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$224.32 - $326.09 $49.8 Million - $72.5 Million
222,225 Added 30.19%
958,336 $313 Million
Q1 2025

May 19, 2025
BUY
$233.07 - $290.7 $5.95 Million - $7.42 Million
25,513 Added 3.59%
736,111 $199 Million
Q4 2024

Feb 14, 2025
BUY
$232.27 - $300.43 $1.01 Million - $1.31 Million
4,367 Added 0.62%
710,598 $167 Million
Q3 2024

Nov 14, 2024
SELL
$233.81 - $287.01 $30.2 Million - $37.1 Million
-129,182 Reduced 15.46%
706,231 $194 Million
Q2 2024

Aug 13, 2024
BUY
$143.31 - $247.0 $11 Million - $19 Million
76,763 Added 10.12%
835,413 $203 Million
Q1 2024

May 15, 2024
BUY
$146.51 - $198.2 $2.58 Million - $3.49 Million
17,589 Added 2.37%
758,650 $113 Million
Q4 2023

Feb 14, 2024
SELL
$151.41 - $196.57 $5.06 Million - $6.57 Million
-33,415 Reduced 4.31%
741,061 $142 Million
Q3 2023

Nov 13, 2023
BUY
$170.77 - $211.65 $17.2 Million - $21.3 Million
100,598 Added 14.93%
774,476 $137 Million
Q1 2023

May 15, 2023
BUY
$182.66 - $235.53 $2.91 Million - $3.76 Million
15,958 Added 2.43%
673,878 $135 Million
Q4 2022

Feb 14, 2023
BUY
$185.53 - $241.31 $10.1 Million - $13.1 Million
54,388 Added 9.01%
657,920 $156 Million
Q3 2022

Nov 14, 2022
BUY
$138.54 - $232.0 $1.43 Million - $2.39 Million
10,310 Added 1.74%
603,532 $121 Million
Q2 2022

Aug 12, 2022
SELL
$120.42 - $169.29 $1.44 Million - $2.02 Million
-11,943 Reduced 1.97%
593,222 $86.5 Million
Q1 2022

May 16, 2022
SELL
$127.18 - $173.91 $4.52 Million - $6.18 Million
-35,545 Reduced 5.55%
605,165 $98.8 Million
Q4 2021

Feb 14, 2022
SELL
$159.56 - $209.29 $775,780 - $1.02 Million
-4,862 Reduced 0.75%
640,710 $109 Million
Q3 2021

Nov 15, 2021
BUY
$169.75 - $207.73 $3.79 Million - $4.64 Million
22,344 Added 3.59%
645,572 $122 Million
Q2 2021

Aug 16, 2021
SELL
$128.63 - $176.89 $5.44 Million - $7.48 Million
-42,301 Reduced 6.36%
623,228 $106 Million
Q1 2021

May 14, 2021
SELL
$126.83 - $175.69 $5.06 Million - $7.01 Million
-39,906 Reduced 5.66%
665,529 $94 Million
Q4 2020

Mar 01, 2021
SELL
$122.97 - $147.0 $2.19 Million - $2.62 Million
-17,790 Reduced 2.46%
705,435 $91.7 Million
Q3 2020

Nov 13, 2020
SELL
$121.19 - $165.49 $13.9 Million - $18.9 Million
-114,402 Reduced 13.66%
723,225 $105 Million
Q2 2020

Aug 14, 2020
BUY
$104.21 - $156.44 $650,374 - $976,342
6,241 Added 0.75%
837,627 $124 Million
Q1 2020

May 15, 2020
BUY
$93.12 - $133.99 $718,607 - $1.03 Million
7,717 Added 0.94%
831,386 $90.5 Million
Q4 2019

Feb 14, 2020
BUY
$74.51 - $124.23 $2.41 Million - $4.02 Million
32,360 Added 4.09%
823,669 $94.9 Million
Q3 2019

Nov 14, 2019
SELL
$70.9 - $87.82 $12.3 Million - $15.2 Million
-173,457 Reduced 17.98%
791,309 $63.6 Million
Q2 2019

Aug 15, 2019
SELL
$65.86 - $92.79 $12.7 Million - $17.9 Million
-193,372 Reduced 16.7%
964,766 $0
Q1 2019

May 14, 2019
SELL
$72.76 - $93.45 $18.9 Million - $24.2 Million
-259,352 Reduced 18.3%
1,158,138 $0
Q4 2018

Feb 13, 2019
BUY
$62.67 - $88.33 $6.05 Million - $8.53 Million
96,532 Added 7.31%
1,417,490 $103 Million
Q3 2018

Nov 14, 2018
SELL
$87.52 - $122.67 $3.29 Million - $4.62 Million
-37,641 Reduced 2.77%
1,320,958 $0
Q2 2018

Aug 14, 2018
BUY
$88.31 - $107.8 $1.54 Million - $1.88 Million
17,428 Added 1.3%
1,358,599 $0
Q1 2018

May 14, 2018
SELL
$115.92 - $148.54 $6.15 Million - $7.88 Million
-53,042 Reduced 3.8%
1,341,171 $0
Q4 2017

Feb 09, 2018
BUY
$114.49 - $139.98 $3.41 Million - $4.17 Million
29,816 Added 2.19%
1,394,213 $0
Q3 2017

Nov 13, 2017
BUY
$72.53 - $118.27 $99 Million - $161 Million
1,364,397
1,364,397 $0

Others Institutions Holding ALNY

# of Institutions
744
Shares Held
115M
Call Options Held
584K
Put Options Held
672K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $55.6B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email